Cellular Origins Partners with ScaleReady for Cell Therapy Manufacturing

Kadeja Johnson
12 May 2023
Automation & Digitisation
Cell Therapy
Collaborations, Mergers & Acquisitions
Scaling Up
Cellular Origins and ScaleReady have announced a joint partnership to integrate ScareReady’s cell and gene therapy manufacturing workflow with Cellular Origins’ robotic technology which will focus on automation of ScaleReady’s G-Rex® platform.

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies announced a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi and Wilson Wolf, to simplify, standardize, and automate cell therapy manufacturing.

Cellular Origins’ and ScaleReady’s first project will be to standardize and automate interconnections between the modules of ScaleReady’s G-Rex®, a manufacturing platform used by therapy developers internationally to produce cell and gene therapies for clinical trials.

Dr Edwin Stone, CEO of Cellular Origins, elaborated on the wide technologies of ScaleReady being utilized in the production of advanced, cell-based therapies:

“This collaboration demonstrates the adaptability of our robotic system, highlighting that it can be integrated seamlessly into existing workflows and allowing therapy developers access to scalable, cost-effective advanced therapy manufacture without significant process redevelopment.”

How are you enjoying this news article? Let us know your thoughts, here >>

The integration of Cellular Origin’s robotic system will support ScaleReady’s beliefs of simplicity and repeatability in practical scaling of CGT manufacturing. Automation has the potential to improve the process of sterile interconnections, an area where labor is dependent. Leveraging of Cellular Origins’ robotic system will eliminate variability in manual connection technique.

 “Our partnership with Cellular Origins is an important step towards ScaleReady’s mission to simplify and standardize CGT manufacture, solving the liquid handling problem and proving how amenable a simple, modular, and scalable approach is to automation allows the field to see a path forward to economies of scale,” added Josh Ludwig, Commercial Director at ScaleReady.

Further projects will automate additional components of ScaleReady’s workflow, such as the robotic movement of G-Rex® into and out of incubators.

Source: Cellular Origins Press Release

While we have you…

We are continuously working to better optimize our content for you, our audience. Let us know how we’re doing by ticking the box below, or send us your feedback directly to team@phacilitate.com.